Elutia CFO Matthew’s March 10 Equity Moves Signal Optimism but Caution for Investors
Elutia CFO Matthew’s March 10 trades reveal disciplined insider buying—boosting his stake to 477k shares—while selling RSUs for tax‑efficient liquidity, hinting confidence in an upcoming NXT‑41x FDA clearance.
3 minutes to read